Neutrophil-derived myeloperoxidase (MPO) is recognized as a major source of oxidative stress at the airway surface of a cystic fibrosis (CF) lung where, despite limited evidence, the antioxidant glutathione is widely considered to be low. The aims of this study were to establish whether oxidative stress or glutathione status are associated with bronchiectasis and whether glutathione deficiency is inherently linked to CF or a consequence of oxidative stress.
Introduction
In CF, neutrophil-dominated inflammation is a hallmark of lung disease, occurs in infancy and is associated with bronchiectasis [1] [2] [3] [4] [5] . Neutrophil elastase (NE) has been identified as a major risk factor for bronchiectasis, but targeting the proteolytic activity in CF has not been shown to improve lung function [2, 6] . Neutrophils are incomparable amongst human cells in their ability to generate large amounts of reactive oxidants [7] . The major oxidants are hypochlorous acid and hypothiocyanite -reactive oxidants produced from hydrogen peroxide by the neutrophil enzyme myeloperoxidase (MPO) [8] . Both oxidants are produced in large amounts in the airways of children with CF, where they oxidize proteins and glutathione [9] [10] [11] [12] . It is not known whether MPO is associated with bronchiectasis.
Glutathione is a major antioxidant that protects the lung against oxidative stress and is present at high concentrations in epithelial lining fluid [13] . In the lungs of patients with cystic fibrosis, glutathione deficiency is widely regarded to occur as a result of impaired glutathione transport across the epithelium by mutated forms of the cystic fibrosis transmembrane conductance regulator (CFTR). While CFTR's contribution to the glutathione efflux has been demonstrated with studies on membrane vesicles [14, 15] , cell cultures [16] and mice [17, 18] , only a few studies have measured glutathione levels in humans. Glutathione was shown to be lower in bronchoalveolar lavage (BAL) and plasma from a small number of CF adults compared to non-CF controls [19] . For infants, glutathione levels were initially reported to be similar in BAL from CF and disease controls without infections, but lower in CF children with pulmonary infections [20] .
Besides, or in addition to a defective CFTR, glutathione levels may be low in the epithelial lining fluid of CF patients because of heightened oxidative stress. Recently, we found that BAL glutathione was markedly lower in CF children than disease controls [10] . It had reacted with hypochlorous acid, and there was elevated attachment of glutathione to airway proteins via S-glutathionylation [10] . However, we could not assess with confidence the extent to which oxidation contributed to low glutathione in CF and whether oxidative stress influenced the development of bronchiectasis.
Uric acid, an abundant molecule in the epithelial lining fluid, is susceptible to oxidation by a variety of oxidants leading to the formation of allantoin [21] [22] [23] . Allantoin has been previously shown to correlate with levels of MPO levels in CF BAL [24] and was considered as a marker of neutrophil-mediated oxidative stress for the purpose of this study.
Several clinical trials have investigated the therapeutic potential of glutathione and other thiol-derivatives in CF, but have delivered conflicting evidence with regard to whether thiols decrease oxidative stress and improve lung function [25, 26] . Unsurprisingly, a recent Cochrane review concluded that more studies are needed, especially in young patients, to explain how oxidative stress and glutathione deficiency contribute to CF lung disease [25] .
The aims of the current study were to investigate in a large cohort of infants and young children with CF whether glutathione levels are low in the epithelial lining fluid, to establish to what extent oxidation contributes to glutathione deficiency, and what effect pulmonary infections have on glutathione levels. We further explored whether glutathione status and neutrophil-mediated oxidative stress are associated bronchiectasis.
Material and methods

Study population
We examined data from 58 children without CF (NCF) under investigation for recurrent respiratory symptoms who provided one BAL sample each and 205 CF children who collectively provided 577 BAL samples (see online data supplement for details). Children with CF were diagnosed following detection by newborn screening and participated in the AREST CF surveillance program conducted in the paediatric CF clinics in Melbourne and Perth. The details of the AREST CF surveillance program including diagnosis of bronchiectasis and infection and measurement of free neutrophil elastase activity, have been previously published [2] and are outlined in the online supplement.
BAL
BAL was performed under general anaesthesia following the CT scan, with the tracheal tube replaced by a laryngeal mask airway for passage of the bronchoscope. The right middle lobe (RML) was lavaged with three aliquots of warmed normal saline (1 ml/kg) and retrieved using low-pressure suction. The first aliquot was used for microbiological analysis. The remaining aliquots were pooled, centrifuged at 1676g for 5 min and the supernatant was decanted. Half of the supernatant was treated with the alkylating reagent N-ethylmaleimide (NEM) (final concentration of 20 mM) to prevent artefactual oxidation.
Measurement of oxidative stress in BAL
MPO and allantoin in BAL were determined by ELISA and stable isotope dilution liquid chromatography tandem mass spectrometry (LC-MS/MS), respectively, as described previously [24, 27] . Further details can be found in the online supplement.
Analysis of glutathione and its oxidation products in BAL
Protein in NEM-treated BAL was precipitated and reduced glutathione (GSH; detected as GS-NEM), oxidized glutathione (GSSG) and glutathione sulfonamide (GSA) were measured in the supernatant by stable isotope dilution LC-MS/MS as described before [28] . GSA is a glutathione metabolite specific to myeloperoxidase-derived hypochlorous acid (Reaction 1) [29] .
The protein pellet was reduced with DTT and glutathione released from proteins (GSSP) was alkylated with iodoacetamide. The resulting carbamidomethyl-GSH was measured by stable isotope dilution LC-MS/ MS. Further details can be found in the online supplement.
The GSSG/GSH ratio was calculated as GSSG/GSH = 2x 
Statistical analyses
Levels of all analytes had right skewed distributions hence log link functions were used in all generalized linear models. MPO, GSA and GSSP had multiple zero values hence a small offset (less than 1%) was applied to MPO, GSA and GSSP before modelling, graphed and tabulated results are on the natural scale with any offset removed.
In the CF patient cohort the probability of developing bronchiectasis was modelled with generalized estimating equations (GEE) using a logit link and first order auto correlation structure on sequential samples from each participant. Models were fitted for bronchiectasis on each volumetric CT scan (151 negative and 200 positive scans from 182 children) and for bronchiectasis on either volumetric or limited slice scan (142 negative and 250 positive scans from 192 children) and each analyte. Models with multiple analytes were also examined. All models included covariates for age (continuous) and gender (dichotomous).
To assess the combined effects of CF and infection (Inf) on glutathione levels and MPO, each analyte was modelled for all participants. The number of BAL samples in each group were 10, 47, 118, 448 in the NCF-Inf, NCF+Inf, CF-Inf and CF+Inf groups, respectively. Generalized estimating equation (GEE) were fitted to each analyte against infection status (dichotomous), CF status (dichotomous) and age (continuous) with a Gaussian error distribution and log link function. Interaction between CF status and infection was tested for each analyte and retained if significant, gender was omitted from final models as it was not significant in any model. A random effect was fitted for participant with an order 1 autocorrelation structure to account for sequential measurements, the average autocorrelation over all participants was 0.21. All models were fitted with REML and residual plots were assessed for fit. GEEs provided estimated analyte levels and 95% confidence intervals for each combination of CF status and infection for each analyte at the median age of 3.4 years; p-values were calculated from contrasts within CF status and within infection status at 3.4 years from the GEE models, presented graphically in Figs. 2 and 3. All analysis was performed in GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA) and R 3.3.1 (Vienna, Austria) with the geepack package [30] .
Results
Levels of glutathione species in BAL from children with and without CF
In the present study we investigated a total of 263 children and infants, out of which 205 had CF and 58 did not (NCF). Collectively they provided 635 BAL samples. Table 1 shows characteristics of patients and their BAL samples. At the time of BAL, more than 80% of children in both groups had pulmonary infections as indicated by positive culture with > 10 5 CFU/ml. BAL from children with CF had a higher mean total cell count (TTC), higher numbers of macrophages and neutrophils, and higher levels of MPO and was more often positive for free neutrophil elastase activity ( Table 1 ). The mean concentration of reduced GSH in BAL from CF children was 68% of the level measured in children without CF (Table 1 , Fig. 1 ). We hypothesized that oxidation of glutathione to GSSG and its attachment to proteins could in part account for the decrease of the reduced form. Indeed in some individuals, the relative amount of glutathione present as GSSG (%GSSG) or attached to proteins (%GSSP) was as high as 91% and 52%, respectively (data not shown). However, like GSH, the mean concentration of GSSG and GSSP, was lower in BAL from CF children compared to NCF children (42% and 58%, respectively, Table 1 , Fig. 1 ). Hence, the total glutathione concentration in BAL was also lower in the CF group (52%, Table 1 , Fig. 1 ). Collectively these results indicate that glutathione is low in individuals with CF from an early age irrespective of oxidation ( Fig. 1 ).
Relationship between glutathione species and markers of neutrophil inflammation and bronchiectasis
The presence of bronchiectasis on chest CT was associated with a doubling of the concentration of GSSP, a greater proportion of glutathione attached to proteins relative to total glutathione (%GSSP), and more MPO in the BAL (Supplementary Table 1 ). Furthermore, interleukin-8 (Il-8), and free NE activity were associated with bronchiectasis (Supplementary Table 1 ) as shown before [1, 2] . There were no significant differences in reduced GSH, total glutathione, GSSG, GSSG/ GSH, GSA or allantoin (Supplementary Table 1) .
We then modelled the probability of having bronchiectasis based on BAL levels of MPO, GSSP or %GSSP accounting for age, gender and sequential sampling from the same patient ( Table 2 ). The odds of having bronchiectasis was increased three-fold when MPO increased by a factor of ten (OR = 3.11, CI = 2.22-4.35, p < 0.001). GSSP and %GSSP were also significantly associated with bronchiectasis. However, including both MPO and GSSP in the model rendered GSSP nonstatistically significant; not surprising given the correlation between MPO and GSSP (r = 0.60, p < 0.001).
Furthermore, all CT scans were positive for bronchiectasis at MPO concentrations in BAL greater than 2200 ng/ml. We also modelled the odds of presenting with bronchiectasis on either a volumetric scan or limited slice scan and the results made no material differences to the conclusions. Levels of GSH were not associated with the presence of bronchiectasis.
The effect of pulmonary infections on levels of glutathione species and MPO in BAL
In children without infections, reduced GSH and the oxidized species GSSG and GSSP were significantly lower in children with CF compared to those without after accounting for age and sequential sampling from the same child (Fig. 2 ). These results demonstrate that a basal glutathione deficiency exists in CF lower respiratory tract that cannot be accounted for by oxidation and in fact includes the oxidized species GSSG and GSSP. For the non-CF children infection did not cause any significant changes in the measures or ratios of glutathione (Fig. 2, Supplementary  Fig. 1 ). In contrast, infected CF children had significantly higher BAL levels of GSSG, GSSP, and the ratio of oxidized to reduced glutathione compared to non-infected CF children (Fig. 2) . The relative amounts of glutathione (%GSH, %GSSG and %GSSP) showed very similar trends ( Supplementary Fig. 1 ). These results demonstrate that in the children with CF, the glutathione-dependent antioxidant response to oxidative stress was inadequate compared to that observed in the children without CF.
In the absence of infections, MPO and its specific product GSA were higher in samples from children with CF compared to samples from those without (Fig. 3) [29] . Thus, even in uninfected CF children there was evidence of neutrophilic inflammation and oxidative stress. With infections, MPO and GSA levels were elevated in both groups, but this only reached statistical significance in the group without CF. Supplementary Fig. 2 shows individual analyte measures for each BAL sample and the predicted mean at age 1 and 5 years. After accounting for CF and infection status, there was a significant effect of age on GSH, GSSG and GSSG/GSH, which decreased on average by 5%, 15% and 10%, per year, respectively. MPO increased by 14% every year.
Relationship between glutathione species and markers of neutrophil inflammation
The oxidized glutathione species, GSSG and GSA were significantly related to each other (r = 0.55, p < 0.001) and levels of GSSG correlated weakly with those of MPO (r = 0.20, p < 0.001) and allantoin (r = 0.22, p < 0.001). GSA was significantly related to neutrophil numbers (r = 0.47, p < 0.001), IL-8 (r = 0.59, p < 0.001), MPO (r = 0.58, p < 0.001) and allantoin (r = 0.43, p < 0.001). These results indicate that GSSG and GSA are related to neutrophilic inflammation as shown previously in a smaller samples size [10] . Free neutrophil elastase correlated with MPO (r = 0.63, p < 0.0001). The relative amount of glutathione attached to proteins (%GSSP) correlated well with markers of neutrophilic inflammation (neutrophil numbers, r = 0.46, p < 0.001; IL-8, r = 0.58, p < 0.001) and of oxidative stress (MPO, r = 0.62, p < 0.001; GSA, 0.60, p < 0.001; GSSG/GSH, r = 0.67, p < 0.001; allantoin, r = 0.34, p < 0.001) (Fig. 4) . The absolute amount of glutathione attached to proteins (GSSP) showed similar correlation coefficients when related to neutrophil numbers, IL-8, MPO, Fig. 2 . Glutathione species in BAL from children with and without CF and pulmonary infections. Samples were grouped into those from children with (CF) and without CF (NCF) and those that had detectable pulmonary infections (+Inf) or not (-Inf). The concentration in BAL of a) reduced glutathione (GSH), b) oxidized glutathione (GSSG), c) glutathione attached to proteins (GSSP), and d) GSSG/ GSH ratio (2x[GSSG]/(2x[GSSG]+[GSH])) were determined. The bar represents the analyte concentration predicted from the GEE model at the median age of 3.4 years and the error bar the 95% confidence intervals, *** p < 0.001 when compared to non-infected patients within the same group; # p < 0.05, ## p < 0.01, ### p < 0.001 when compared to the patients with same infection status in the NCF group. Fig. 3 . Markers of neutrophil-mediated oxidative stress in BAL from children with and without CF and pulmonary infections. Samples were grouped into those from children with (CF) and without CF (NCF) and those that had detectable pulmonary infections (+Inf) or not (-Inf). The concentration in BAL of a) MPO and b) glutathione sulfonamide (GSA) was determined. The bar represents the analyte concentration predicted from the GEE model at the median age of 3.4 years and the error bar the 95% confidence intervals, *** p < 0.001 when compared to non-infected patients within the same group; ### p < 0.001 when compared to the patients with same infection status in the NCF group.
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GSA, allantoin and GSH/GSSG (r = 0.51, 0.58, 0.58, 0.69, 0.40, 0.61, respectively, p < 0.001 for all). These data suggest that reactive oxidant species produced by neutrophils contribute to the oxidation of glutathione in the airways of children with CF.
Discussion
Our study is the first to demonstrate that the presence of bronchiectasis in CF children is strongly associated with levels of neutrophilderived MPO in BAL and glutathionylation of airway proteins. Furthermore, by investigating a large cohort of young children, we have established that there is a deficiency of glutathione in CF BAL -approximately 60% of the levels found in BAL from children without CF.
The observed glutathione deficiency is not due to increased oxidation because measuring all major oxidation products of glutathione could not account for the observed decrease of reduced glutathione. Thus, it is likely that glutathione deficiency occurs in the epithelial lining fluid of patients with CF because of defective transport by mutated CFTR, as previously proposed [15, 16, 18] . Lung infections predispose CF children to bronchiectasis [1, 2] . Our results from this and previous studies indicate that CF children with infections experience highly elevated oxidative stress compared to non-CF children [9, 11, 12, 24] . The combination of decreased glutathione and increased oxidant production in the lungs of CF patients may set the antioxidant balance to a tipping point towards a state of marked oxidative stress. CF airways will be subjected to oxidative insults that are likely to contribute to the development of bronchiectasis (Fig. 5) . Indeed, the inability to maintain the ratio of oxidized to reduced glutathione during infection in the CF airway, as occurred in non-CF children, suggests that mutated CFTR cannot transport reduced glutathione into the airways fast enough to quell oxidative stress. Consequently, oxidative stress should be considered as an etiological factor in the development of bronchiectasis in CF.
CF is characterized by chronic infiltration of neutrophils into the lung epithelium to combat infections, but once activated, neutrophils release reactive oxygen species (ROS) including MPO-derived hypochlorous acid [9, 11, 31] . We hypothesized that oxidation of GSH to GSSG and GSSP contributes to a previously observed deficiency of reduced glutathione in the CF airway [19] . Indeed, we found that in individual BAL samples, GSSG and GSSP can constitute more than 50% of the total glutathione concentration. As predicted, GSSG and GSSP were elevated with pulmonary infection and correlated with markers of neutrophilic inflammation and oxidative stress. However, even in the absence of infections the glutathione concentration was significantly lower in the BAL of children with CF compared to those without. Our data therefore strongly suggests that an inherent airway deficiency of glutathione exists in CF children from an early age.
Recent therapeutic advances in CF lung disease include the use of CFTR potentiators for patients carrying the G551D mutation and other gating mutations [32] . Measuring glutathione levels in BAL from children receiving CFTR-correcting or gene therapies would establish whether glutathione deficiency stems from a compromised transport by mutated CFTR.
GSH is usually present in very high concentrations in the epithelial lining fluid and plays and important role in the antioxidant defence of the lower respiratory tract [13] . The fact that it is low in the epithelial lining fluid of individuals with CF is likely to underpin the neutrophilmediated oxidative protein damage previously observed in CF lungs [9, 10, 12] . Our data did not reveal a significant association between GSH levels and bronchiectasis in this paediatric CF population. It is possible, however, that because levels of GSH are generally low there is not a great enough dynamic range to detect a relationship with bronchiectasis. Similarly, while small molecule markers of oxidative stress (GSA, GSSG) were elevated in BAL with infections, they were not related to bronchiectasis. On the other hand, protein markers of neutrophil-mediated inflammation and oxidative damage measured in the current study, i.e. IL-8, NE, MPO and GSSP, were significantly higher in individuals with bronchiectasis. We have previously shown that GSA is slightly elevated in urine and serum from CF children with bronchiectasis [24] . It is possible that unlike protein markers, small molecules like GSA fail to indicate bronchiectasis when measured in BAL as they are more rapidly cleared from the lung.
When we investigated the effect of infections on BAL glutathione, we noted a differential response in children with and without CF. While both groups of children experienced a slight decrease of reduced glutathione with infection, only CF children showed a significant increase . If an analyte concentration was below the limit of detection, a value half the lower limit of detection (LOD) was assigned.
in oxidized glutathione species, GSSG and GSSP, and the GSSG/GSH ratio. This finding suggests that in contrast to a CF lung, the non-CF lung is able to regulate oxidized glutathione species possibly by transporting more reduced glutathione to the extracellular space. Day et al. previously observed that wild-type but not CFTR knockout mice responded to an infection with Pseudomonas aeruginosa by increasing GSH levels in the epithelial lining fluid [17] . Both our present study and the study in mice demonstrate that mutated CFTR leads to an inadequate glutathione-related antioxidant response to pulmonary infections.
Neutrophil elastase has previously been reported as major risk factor for bronchiectasis [2] . Here, we report that levels of neutrophilderived MPO and oxidative modifications of proteins in children and infants with CF can also predict the presence of bronchiectasis. Furthermore, we found that MPO and GSA were elevated in the absence of detectable infections in CF children compared to non-CF children. These findings are supported by other studies reporting an infectionindependent neutrophilic inflammation in the CF lung [4, 5] . Collectively, our findings suggest that neutrophils are associated with a worse outcome in early cystic fibrosis lung disease both via MPO-mediated oxidative and proteolytic damage of proteins. While inhibition of NE activity has already been explored as a treatment avenue in CF [6] , studying the effects of MPO inhibition is warranted. The endogenous NE inhibitor, α-1-antitrypsin, becomes inactivated by oxidants [33] . Stopping MPO-related oxidant production might therefore also inhibit NE activity indirectly by maintaining the activity of α-1-antitrypsin.
Since the early reports of impaired glutathione efflux in CF, inhaled GSH has been the focus of a number of treatment trials, which demonstrated either unsatisfactory or conflicting data with regard to improvement of lung function and decrease of oxidative stress [34] [35] [36] [37] [38] [39] . While efficient delivery of GSH to the epithelial lining fluid was achieved, some of the supplied glutathione was rapidly oxidized to GSSG indicating the presence of oxidants, and possibly counteracting the intended benefit of the therapy [37, 38] . Inhibition of MPO would block oxidant production at the source and might help restore glutathione levels at the same time as decreasing oxidative stress. Also, long term treatment with inhaled glutathione may be beneficial, an avenue only one study has explored to date [35] . Furthermore, all studies on inhaled glutathione were done on patients older than six years. Given our results showing that glutathione deficiency and bronchiectasis exist early in life, we suggest that therapeutic benefit could be gained from a longer term treatment that commences in infancy. Additionally, if glutathione transport is dependent on functional CFTR, therapies with CFTR correctors would also correct this pathological aspect of CF lung disease in some children if administered early in life.
Finally we would like to acknowledge the limitations of our study. As part of the AREST CF program, children undergo chest CT and BAL once a year when they are fit for anaesthesia. Our data therefore provide a yearly snapshot and reflect a clinically stable condition as opposed to an acute respiratory condition. Furthermore, our data reflect the airway compartments reached by BAL in young children, most likely small airways. Levels of antioxidants including glutathione in other airway compartments may differ from those reported here. 5 . Model of the contribution of neutrophilic inflammation, oxidative stress and glutathione deficiency to the development of bronchiectasis in the airway of a child with cystic fibrosis. During a pulmonary infection, activated neutrophils release neutrophil elastase and myeloperoxidase (MPO). In CF airways, levels of the antioxidant glutathione are insufficient to protect against oxidative stress exerted by MPO resulting in increased S-glutathionylation of airway proteins and protein damage. The majority of children with CF have radiological evidence of bronchiectasis before they reach school age. In contrast, in non-CF airways, the antioxidant glutathione protects the airways from oxidative stress during the infection until bacteria and neutrophils are cleared from the lung. Normal and low concentrations of chloride (Cl -), bicarbonate (HCO 3 -) and glutathione (GSH) are indicated by bold black and light grey letters, respectively.
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In conclusion
We show that glutathione deficiency exists in the lower respiratory tract during early stages of cystic fibrosis lung disease. At the same time the lung suffers from neutrophil-mediated oxidative stress highlighting the need for effective glutathione delivery to sites of inflammation. Neutrophils contribute to the pathology of the disease both via oxidative and proteolytic modification of proteins. Thus, treatments targeting low glutathione, NE and MPO have potential therapeutic benefits for CF patients.
